AMARIN CORP PLC\UK Increase (Decrease) in Derivative Liabilities
AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Derivative Liabilities of $1.37 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2017-03-01
- AMARIN CORP PLC\UK increase (decrease) in derivative liabilities for the quarter ending 2015-12-31 was $500.00K.
- AMARIN CORP PLC\UK increase (decrease) in derivative liabilities for the quarter ending 2015-09-30 was $0.00.
- AMARIN CORP PLC\UK increase (decrease) in derivative liabilities for the quarter ending 2015-06-30 was $0.00.
- AMARIN CORP PLC\UK increase (decrease) in derivative liabilities for the quarter ending 2015-03-31 was $868.00K.
- AMARIN CORP PLC\UK increase (decrease) in derivative liabilities for fiscal 2015 was $1.37M.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2015-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $500.00K derived: sum of 2 quarters · filed 2017-03-01 | $500.00K derived: sum of 3 quarters · filed 2017-03-01 | $1.37M 10-K · filed 2017-03-01 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $868.00K 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $868.00K 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $868.00K 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |